Inovio Pharma (INO) Misses Q2 EPS by 14c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.10 -2.65%
EPS Growth %: +60.7%
Financial Fact:
Loss from investment in affiliated entity: -958.14K
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: +60.7%
Financial Fact:
Loss from investment in affiliated entity: -958.14K
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q2 EPS of ($0.39), $0.14 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $273 thousand versus the consensus estimate of $1.21 million.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
- Paychex beats fourth quarter EPS estimates, stock slides
- Colony Bankcorp to acquire First Reliance in $163M stock-and-cash deal
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
